TELANGIECTASIA CONGENITAL

This adverse event was reported 19 times

These drugs are most commonly taken by patients reporting TELANGIECTASIA CONGENITAL:

# Drug Count
0 DULOXETINE 9
1 DULOXETINE HYDROCHLORIDE 9
2 PREGABALIN 9
3 QUETIAPINE 5
4 FOLIC ACID 2
5 TOPIRAMATE 2
6 BELIMUMAB 1
7 DINOPROSTONE 1
8 HYDROXYCHLOROQUINE 1
9 PREDNISONE 1
See all common drugs associated with TELANGIECTASIA CONGENITAL

TELANGIECTASIA CONGENITAL is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DINOPROSTONE 1 0.0012
1 PROPYLTHIOURACIL 1 0.0005
2 DULOXETINE HYDROCHLORIDE 9 0.0001
3 VALPROATE SODIUM 1 0.0000
4 TOPIRAMATE 2 0.0000
5 PREGABALIN 9 0.0000
6 BELIMUMAB 1 0.0000
7 QUETIAPINE 5 0.0000
8 FOLIC ACID 2 0.0000
9 PREDNISONE 1 0.0000
See all drugs enriched for association with TELANGIECTASIA CONGENITAL

TELANGIECTASIA CONGENITAL is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Thyroid Hormone Synthesis Inhibitor [EPC] 1 0.0001
1 B Lymphocyte Stimulator-specific Inhibitor [EPC] 1 0.0000
2 Atypical Antipsychotic [EPC] 5 0.0000
3 Prostaglandin Analog [EPC] 1 0.0000
4 Vitamin D [EPC] 2 0.0000
5 Vitamin B12 [EPC] 2 0.0000
6 Vitamin C [EPC] 2 0.0000
7 Corticosteroid [EPC] 1 0.0000
See all drug classes enriched for association with TELANGIECTASIA CONGENITAL